MedTrace Logo

Psychological Health and Adverse Childhood Experiences in Myasthenia Gravis: Online Mental Health BMI Learning Program

NCT07291713 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 77

Last updated 2025-12-18

No results posted yet for this study

Summary

This study evaluated psychological health in patients with myasthenia gravis (MG) using an online behavioral program called the "Positive Mental Health BMI Learning Program." The program consisted of four short video units focused on interpersonal support, emotional regulation, and personal meaning. Patients receiving care in the neurology outpatient clinic were invited to complete questionnaires before and after viewing the online program. Psychological well-being, depressive symptoms, daily functioning, and quality of life were assessed to describe participants' mental health status and changes observed over the course of the program.

Conditions

  • Myasthenia Gravis
  • Adverse Childhood Experience
  • Psychological Well-being
  • Mental Well-being
  • Depressive Symptoms
  • Psychological Stress
  • Quality of Life (QOL)
  • Activities of Daily Living
  • Emotional Regulation
  • Mental Health
  • Well-Being, Psychological

Interventions

BEHAVIORAL

Positive Mental Health BMI Learning Program

The intervention consisted of the Positive Mental Health BMI Learning Program, a four-unit online behavioral program delivered through a closed Facebook group. Each video unit was approximately 15 minutes and focused on components of positive mental health, including interpersonal support, emotional regulation, and sense of meaning and self-worth. One unit was released each month over a four-month period. Participants completed pre-test assessments before the program and post-test assessments after completing all four units.

Sponsors & Collaborators

  • Jiann-Horng Yeh

    lead OTHER

Principal Investigators

  • Jiann-Horng Yeh, MD · Shin Kong Wu Ho-Su Memorial Hospital

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-10
Primary Completion
2025-01-09
Completion
2025-01-09

Countries

  • Taiwan

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07291713 on ClinicalTrials.gov